BIOQUAL, Inc.
BIOQ
$37.51
-$0.19-0.50%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 88.67% | 63.16% | 91.78% | 240.36% | -350.09% |
| Total Depreciation and Amortization | -9.12% | -2.77% | 41.91% | -7.14% | -43.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.81% | -- | -54.50% | -30.07% | 93.16% |
| Change in Net Operating Assets | 15.06% | 89.50% | 25.97% | -273,600.00% | -279.30% |
| Cash from Operations | -0.37% | 176.13% | 56.85% | -85.29% | -148.48% |
| Capital Expenditure | -2,285.93% | -- | 86.48% | 91.93% | 92.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -47,625.93% | -- | 86.48% | 91.93% | 92.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 0.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -233.07% | 166.98% | 63.67% | -84.63% | -168.97% |